Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,349 | 29,766 | 52,990 | 66,745 | 100,681 |
| Marketable Securities | 130,180 | 215,916 | 287,613 | 299,193 | 52,078 |
| Receivables | 10,336 | 16,508 | 11,611 | 30,936 | 59,750 |
| TOTAL | $205,330 | $265,591 | $357,167 | $399,421 | $214,302 |
| Non-Current Assets | |||||
| PPE Net | 25,422 | 24,699 | 22,380 | 13,327 | 9,003 |
| Intangibles | 4,589 | 5,650 | 6,711 | 7,772 | 2,486 |
| Other Non-Current Assets | 20,875 | 20,875 | 20,371 | 389 | 1,778 |
| TOTAL | $50,886 | $51,224 | $49,462 | $21,488 | $13,267 |
| Total Assets | $256,216 | $316,815 | $406,629 | $420,909 | $227,569 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,433 | 6,307 | 3,580 | 4,709 | 4,394 |
| Accrued Expenses | 10,348 | 11,447 | 9,641 | 9,131 | 9,098 |
| Other current liabilities | 518 | 496 | 514 | 32 | N/A |
| TOTAL | $23,789 | $21,942 | $18,161 | $16,028 | $17,652 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,490 | 3,692 | 4,426 | 2,156 | 2,173 |
| Other Non-Current Liabilities | 551 | 1,012 | 712 | 195 | 51 |
| TOTAL | $26,059 | $25,036 | $27,981 | $1,803 | $3,814 |
| Total Liabilities | $49,848 | $46,978 | $46,142 | $17,831 | $21,466 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,973 | 52,476 | 51,746 | 51,335 | 49,939 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -369,059 | -270,459 | -162,051 | -103,403 | -283,759 |
| Other shareholders' equity | -16 | 25 | 111 | -81 | -16 |
| TOTAL | $206,368 | $269,837 | $360,487 | $403,078 | $206,103 |
| Total Liabilities And Equity | $256,216 | $316,815 | $406,629 | $420,909 | $227,569 |